Exact Mass: 416.2496
Exact Mass Matches: 416.2496
Found 465 metabolites which its exact mass value is equals to given mass value 416.2496
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Alfentanil
A short-acting opioid anesthetic and analgesic derivative of fentanyl. It produces an early peak analgesic effect and fast recovery of consciousness. Alfentanil is effective as an anesthetic during surgery, for supplementation of analgesia during surgical procedures, and as an analgesic for critically ill patients. [PubChem] D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general > N01AH - Opioid anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
Distigmine
ATC code: N07AA03
manoalide
A sesterterpenoid isolated from the marine sponge Luffariella variabilis and which has been shown to exhibit inhibitory activity towards phospholipase A2. D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Colupox b
Colupox b is found in alcoholic beverages. Colupox b is isolated from hops. Isolated from hops. Colupox b is found in alcoholic beverages.
Forasartan
Forasartan, a specific angiotensin II antagonist, is used alone or with other antihypertensive agents to treat hypertension. Forasartan competes with angiotensin II for binding at the AT1 receptor subtype. As angiotensin II is a vasoconstrictor which also stimulates the synthesis and release of aldosterone, blockage of its effects results in a decreases in systemic vascular resistance. C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist
Efegatran
Elarofiban
3alpha-Angeloyloxy-18-hydroxy-ent-labd-8(17)-13dien-15,16-olide
(2E,6E,9E)-11-Hydroxy-7-(hydroxymethyl)-4,11-dimethyl-4-(4-methyl-3-penten-1-yl)-8-oxo-2,6,9-cycloundecatrien-1-yl 3-methyl-2-butenoate
Distigmine
N - Nervous system > N07 - Other nervous system drugs > N07A - Parasympathomimetics > N07AA - Anticholinesterases D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D004791 - Enzyme Inhibitors
(ent-15beta)-16alpha,17-Epoxide,15-angeloyl-15-Hydroxy-16-kauren-19-oic acid|Perymenic acid
7alpha-methoxy-8,11,13-abietatriene-18-succinic acid|abiesadine G
15-alpha-angeloyloxykauren-19-oic acid 16-epoxide|15-angeloyloxy-16,17-epoxy-19-kauronoic acid
(12E,20Z,18S)-7,8-dihydro-8-hydroxyvariabilin|(12E,20Z,18S)-8-Hydroxyvariabilin|6, 7-Dihydro, 7-hydroxy-Variabilin+
(4R,5S,7S,8S,10R,11R,2S)-7-angeloyloxy-8-(alpha-methylbutyryloxy)longipin-2-en-1-one
21,24,25,26,27-pentanor-15,22-oxo-7alpha,23-dihydroxy-apotirucalla(eupha)-1-en-3-one
3,6-Di-O-acetylasterone|3beta,6alpha-Diacetoxy-5alpha-pregn-9(11)-en-20-on|3beta,6alpha-diacetoxy-5alpha-pregn-9(11)-en-20-one|diacetyl asterone
15-Angeloyl-(ent-15beta)-9, 15-Dihydroxy-16-kauren-19-oic acid|15alpha-angeloyloxy-9beta-hydroxy-ent-kaurenic acid
ent-3beta-hydroxy-14beta-tigloyloxybeyer-15-en-19-oic acid
Di-Ac-(3beta,4beta,5alpha,17(20)Z)-en-16-one-3,4-Dihydroxypregn-17(20)-en-16-one
6alpha,8alpha-dihydroxy-23-oxo-13(14),15,17-trien-16,19-olide
(5S,6E,10R)-5-beta-D-glucopyranosyloxy-3,10-dihydroxy-3,7,11-trimethyldodeca-1,5,11-triene|amarantholidoside II
11,12-Dihydroxy-19-(3-methyl-2-butanoyloxy)-8,11,13-abietatrien-7-on
3beta(H)-7beta,9alpha-diangelyloxy-1-oxolongipinane
2alpha-(2-methylbutyryloxy)-15,16-epoxylabda-7,13(16),14-trien-18-oic acid|2alpha-<2-methylbutyryloxy>-15,16-epoxylabda-7,13(16),14-trien-18-oic acid
6alpha,15(S)-dihydroxy-23-oxo-labd-8(22),13(14),17-trien-16(S),19-olide
(1S,4S,5R,7R,10R)-11,14-dihydroxyguai-3-one 11-O-beta-D-glucopyranoside|(1S,4S,5R,7R,10R)-11,14-Dihydroxyguai-3-one 11-O-??-D-glucopyranoside|(1S,4S,5R,7R,10R)-11,14-dihydroxyguaian-3-one 11-O-beta-D-glucopyranoside
8alpha-23-dihydroxy-23,6alpha-epoxy-labd-13(14),15,17-trien-16,19-olide
(11S)-7-eudesmene-1beta,4beta,12-triol 1-O-beta-D-glucopyranose|iwayoside C
(5Z)-6-[5-(2-beta-D-glucopyranosyloxy-propan-2-yl)-2-methyltetrahydrofuran-2-yl]-3-methylhexa-1,5-dien-3-ol|shanyeside B
1-hydroperoxy-7,10-dihydroxybisabola-2,11-diene 7-beta-D-fucopyranoside
1-hydroperoxy-7,12-dihydroxybisabola-2,10-diene 7-beta-D-fucopyranoside
muurol-4-ene-1beta,3beta,10beta-triol 3-O-beta-D-glucopyranoside|rel-(2R,4aS,5R,8R,8aS)-1,2,4a,5,6,7,8,8a-octahydro-8,8a-dihydroxy-3,8-dimethyl-5-(1-methylethyl)naphthalen-2-yl beta-D-glucopyranoside
muurol-4-ene-1beta,3beta,15-triol 3-O-beta-D-glucopyranoside|rel-(2R,4aS,5R,8S,8aR)-1,2,4a,5,6,7,8,8a-octahydro-8a-hydroxy-3-(hydroxymethyl)-8-methyl-5-(1-methylethyl)naphthalen-2-yl beta-D-glucopyranoside
(3beta,5beta,14beta,16beta,20Z)-16-acetoxy-14,15-epoxy-3-hydroxy-24-norcholan-20(22)-en-21-al
(3R,3aR,5R,5aR,9S,11S,13bR)-3-[(2E)-erythro-4,5-dihydroxyhex-2-en-2-yl]-5,9-dihydroxy-3a-methyl-1,2,3,3a,4,5,5a,8,9,10,11,13b-dodecahydro-12H-6,11-methanocyclodeca[e]inden-12-one|erythro-11alpha-hydroxyneocyclocitrinol
beta-methyl-15-hydroxymethylfaurinone-9-alpha-O-beta-D-glucoside|cupressusoside
(ent-15beta)-2,3-Epoxy-2-methylbutanoyl-15-Hydroxy-16-kauren-19-oic acid|Epoxyangeloxygrandifloric acid
(3alpha,9alpha,10??)-9,10-Dihydroxy-5-longipinanone
abiesadine K|methyl 15-hydroxy-8,11,13-abietatriene-18-succinate
abiesadine H|methyl 7alpha-hydroxy-8,11,13-abietatriene-18-succinate
(5Z)-6-[5-(2-hydroxypropan-2-yl)-2-methyltetrahydrofuran-2-yl]-3-methylhexa-1,5-dien-3-O-beta-D-glucopyranoside
(5S,6E,9E)-5-beta-D-glucopyranosyloxy-3,11-dihydroxy-3,7,11-trimethyldodeca-1,6,9-triene|amarantholidoside I
1beta,6beta,9alpha-trihydroxy-trans-eudesm-3-ene-6-O-beta-D-glucopyranoside
2alpha-isovaleryloxy-15,16-epoxylabda-7,13(16),14-trien-18-oic acid
15-methoxy-8,11,13-abietatriene-18-succinic acid|abiesadine J
6alpha,11-Dihydroxy-19-(3-methyl-2-butanoyloxy)-7,9(11),13-abietatrien-12-on
2alpha,7-dihydroxykessane 2-O-beta-D-glucopyranoside
15-(3-Methyl-2-butenoyl)-(ent-15beta)-9, 15-Dihydroxy-16-kauren-19-oic acid|9beta-hydroxy-15alpha-senecioyloxy-ent-kaurenic acid|9beta-hydroxy-15alpha-senecioyloxy-ent-kaurenoic acid
(Z)-(1R,3R,4R,4aS,8R,8aR)-3,4,8,8a-Tetramethyl-7-oxo-4-(2-(5-oxo-2,5-dihydrofuran-3-yl)ethyl)decahydronaphthalen-1-yl 2-methylbut-2-enoate
ALFENTANIL
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics N - Nervous system > N01 - Anesthetics > N01A - Anesthetics, general > N01AH - Opioid anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics
C25H36O5_2-Butenoic acid, 2-methyl-, (4R,6R)-3,3,7,9-tetramethyl-6-(3-methyl-1-oxobutoxy)-11-oxotricyclo[5.4.0.0~2,8~]undec-9-en-4-yl ester, (2Z)
Gly Gly Lys Arg
Gly Gly Arg Lys
Gly Lys Gly Arg
Gly Lys Arg Gly
Gly Arg Gly Lys
Gly Arg Lys Gly
Lys Gly Gly Arg
Lys Gly Arg Gly
Lys Arg Gly Gly
Arg Gly Gly Lys
Arg Gly Lys Gly
Arg Lys Gly Gly
Forasartan
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist
6-AMINO-5-(2,2-DIETHOXYETHYL)-2-((4-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO)PYRIMIDIN-4(3H)-ONE
6-AMINO-5-(2,2-DIETHOXYETHYL)-2-((3-(4-METHYLPIPERAZIN-1-YL)PHENYL)AMINO)PYRIMIDIN-4(3H)-ONE
1-BOC-4-[4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZOYL]-PIPERAZINE
tert-butyl 4-[[2-(5-amino-3-methyl-1H-pyrazol-4-yl)-6-methoxy-phe noxy]methyl]piperidine-1-carboxylate
methyl 4-(10,13-dimethyl-3,7,12-trioxo-1,2,4,5,6,8,9,11,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl)pentanoate
1,3,8-Triazaspiro[4.5]dec-3-en-2-one, 4-(cyclohexylamino)-1-phenyl-8-(phenylmethyl)-
NCT-501
NCT-501 is a potent and selective theophylline-based inhibitor of aldehyde dehydrogenase 1A1 (ALDH1A1), inhibits hALDH1A1 with IC50 of 40 nM, typically shows better selectivity over other ALDH isozymes and other dehydrogenases (hALDH1B1, hALDH3A1, and hALDH2, IC50 >57 μM).
tert-Butyl 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl)piperazine-1-carboxylate
Tonapofylline
C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator Tonapofylline (BG 9928) is an orally active and selective adenosine A1 receptor antagonist with a Ki of 7.4 nM for human adenosine A1 receptor (hA1), which displays 915-fold selectivity versus human adenosine A2A receptor and 12-fold selectivity versus human adenosine A2B receptor and is used in development for the treatment of heart failure[1][2].
Pregnenolone succinate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone
Trecetilide
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent
3,17-Bis[(trimethylsilyl)oxy]estra-1,3,5(10)-triene
2-hydroxy-3-[6-hydroxy-5-[(E)-4-methyl-6-(2,6,6-trimethylcyclohexen-1-yl)hex-3-enyl]-3,6-dihydro-2H-pyran-2-yl]-2H-furan-5-one
vibsanin B
A vibsane diterpenoid that is (2Z,6E,10E)-cycloundeca-2,6,10-trien-1-one which is substituted at positions 2, 5, 5, 8, 9, and 9 by hydroxymethyl, methyl, 2-methylpent-2-en-5-yl, 3-methylbut-2-enoyloxy, hydroxy, and methyl groups, respectively (the 5S,8R,9R stereoisomer). It has been found to inhibit root growth in rice seedlings (IC50 0.14 mM).
5-Benzyl-2,3-bis(4-methoxyphenyl)-1,4-dimethylpiperazine
4-[[(3S,10R,13S,17S)-17-acetyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid
2-[4-(2,3-Dimethylphenyl)-1-piperazinyl]-1-(8-methyl-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)ethanone
16alpha,17beta-Dihydroxy-androst-4-en-3-one dipropionate
(3R)-3-[(2E,6E)-9-[(2S)-3,3-dimethyloxiran-2-yl]-3,7-dimethylnona-2,6-dienyl]-6-hydroxy-2,3,5-trimethyl-4-oxocyclohexa-1,5-diene-1-carboxylic acid
16alpha,17beta-Dihydroxyandrost-4-en-3-one dipropionate
(1e)-2-[(3s,4r,5s,7r)-7-hydroxy-5-methyl-5-(4-methylpent-3-en-1-yl)-3-(2-oxopropyl)-3,4,6,7-tetrahydro-1h-2-benzofuran-4-yl]ethenyl 3-methylbut-2-enoate
(3s,6s,12s)-12-benzyl-5,11-dihydroxy-1,6,7-trimethyl-3-(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione
(1e)-2-[(1s,5s,7r,8s,11r)-11-(2-hydroxypropan-2-yl)-8-methyl-5-(2-oxopropyl)-4-oxatricyclo[6.3.1.0²,⁶]dodec-2(6)-en-7-yl]ethenyl 3-methylbut-2-enoate
3-{5-[(2-hydroxy-5-methoxy-3-methylphenyl)methyl]-5,6,8a-trimethyl-2-oxo-hexahydro-1h-naphthalen-1-yl}propanoic acid
3-heptyl-7-methyl-6,8-dioxoisochromen-7-yl octanoate
10-hydroxy-9-[4-(5-hydroxy-3-methyl-2-oxocyclopent-3-en-1-yl)-3-methylbut-3-en-1-yl]-4,8,10-trimethyl-2-oxatricyclo[6.3.1.0⁴,¹²]dodecan-3-one
(2s,3r,4s,5s,6r)-2-{[(1s,2s,4ar,6r,7s,8ar)-1,6-dihydroxy-1,4a-dimethyl-7-(prop-1-en-2-yl)-octahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1e)-2-[(1s,5s,7r,8s,11s)-11-(2-hydroxypropan-2-yl)-8-methyl-5-(2-oxopropyl)-4-oxatricyclo[6.3.1.0²,⁶]dodec-2(6)-en-7-yl]ethenyl 3-methylbut-2-enoate
4-{5-[2-(2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl)ethyl]-6-hydroxy-3,6-dihydro-2h-pyran-2-yl}-5-hydroxy-5h-furan-2-one
(1r,2r,3z,5s,7e,11s)-8-formyl-5-[(2e)-4-hydroxy-4-methylpent-2-en-1-yl]-1,5-dimethyl-12-oxabicyclo[9.1.0]dodeca-3,7-dien-2-yl 3-methylbut-2-enoate
2-[1,5,5-trimethyl-9-oxo-10-(2-oxopropyl)-6-oxatricyclo[6.3.2.0⁴,¹³]tridecan-11-yl]ethenyl 3-methylbut-2-enoate
(1r,3r,4ar,5s,8ar)-5-[2-(furan-3-yl)ethyl]-1,4a,6-trimethyl-3-[(3-methylbutanoyl)oxy]-2,3,4,5,8,8a-hexahydronaphthalene-1-carboxylic acid
(1r,2s,4s,5s,7r,8s,9r)-3,3,7,9-tetramethyl-5-{[(2z)-2-methylbut-2-enoyl]oxy}-11-oxotricyclo[5.4.0.0²,⁸]undecan-4-yl (2z)-2-methylbut-2-enoate
(1as,3as,4r,5r,7r,7as,7br)-4,5,7a,7b-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1ah-naphtho[1,2-b]oxiren-7-yl (2e)-2-methylbut-2-enoate
2-[11-(2-hydroxypropan-2-yl)-8-methyl-5-(2-oxopropyl)-4-oxatricyclo[6.3.1.0²,⁶]dodec-2(6)-en-7-yl]ethenyl 3-methylbut-2-enoate
1-[(1r,4s,5r,9s,10s,13r)-5-formyl-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-13-yl]methyl 4-methyl butanedioate
(1'r,2s,3r,4s,8'r,10'r,11'r,12's)-5'-methoxy-4,5,5,6',10',12'-hexamethyl-14'-oxaspiro[oxolane-2,13'-tetracyclo[9.3.2.0¹,¹⁰.0²,⁷]hexadecane]-2',4',6'-triene-3,8'-diol
(2r,3r,4s,5s,6r)-2-{[(1s,1ar,3ar,4s,7r,7as,7bs)-4-hydroxy-1-(hydroxymethyl)-1,7-dimethyl-octahydro-1ah-cyclopropa[a]naphthalen-4-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2e,5e)-2-[(3r)-3-hydroxy-3-[(2r)-2-hydroxy-5-oxo-2h-furan-3-yl]propylidene]-6-methyl-8-[(1s)-2,6,6-trimethylcyclohex-2-en-1-yl]oct-5-enal
(1r,2s,4r,6r,7r,8r)-3,3,7,9-tetramethyl-6-[(3-methylbutanoyl)oxy]-11-oxotricyclo[5.4.0.0²,⁸]undec-9-en-4-yl (2z)-2-methylbut-2-enoate
1-{1-[2-(furan-3-yl)ethyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl}methyl 4-methyl butanedioate
(2r,3s,4s,5s,6s)-2-{[(1r,1ar,4s,4as,7r,7as,7bs)-4-hydroxy-1-(hydroxymethyl)-1,7-dimethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,4r,5s,9s,13s,15s)-6-[(2s,3e,5r)-2,5-dihydroxyhex-3-en-2-yl]-4,15-dihydroxy-5-methyltetracyclo[11.4.1.0²,¹⁰.0⁵,⁹]octadeca-1(17),10-dien-12-one
2-{[2-(6,7-dihydroxy-4a-methyl-8-methylidene-octahydronaphthalen-2-yl)propan-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1r,4s,5r,9s,10s,13r,15s)-15-[(2s,3r)-2,3-dimethyloxirane-2-carbonyloxy]-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylic acid
(1z)-2-[(1r,2r,7s)-4-(hydroxymethyl)-2-methyl-2-(4-methylpent-3-en-1-yl)-5-oxo-7-(2-oxopropyl)cyclohept-3-en-1-yl]ethenyl 3-methylbut-2-enoate
2-{[1,6-dihydroxy-1,4a-dimethyl-7-(prop-1-en-2-yl)-octahydronaphthalen-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,3as,4r,7r,8ar)-4-(hydroxymethyl)-1-methyl-7-(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propan-2-yl)-octahydro-1h-azulen-2-one
2-{[2,4-dihydroxy-4,8a-dimethyl-6-(prop-1-en-2-yl)-octahydronaphthalen-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1e)-2-[11-(2-hydroxypropan-2-yl)-8-methyl-5-(2-oxopropyl)-4-oxatricyclo[6.3.1.0²,⁶]dodec-2(6)-en-7-yl]ethenyl 3-methylbut-2-enoate
(1ar,3ar,4r,5s,6s,7ar,7bs)-4,5,7a,7b-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1ah-naphtho[1,2-b]oxiren-6-yl (2z)-2-methylbut-2-enoate
methyl (2s)-2-[(3r,6r)-6-[(2s,3as,4r,9bs)-3a,4,7,9b-tetramethyl-2h,3h,4h,5h-naphtho[1,2-b]furan-2-yl]-6-methyl-1,2-dioxan-3-yl]propanoate
(2r,3r,4s,5s,6r)-2-{[(3s,5s,6e,9e)-3,11-dihydroxy-3,7,11-trimethyldodeca-1,6,9-trien-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1as,3as,4r,5r,7r,7as,7br)-4,5,7a,7b-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1ah-naphtho[1,2-b]oxiren-7-yl (2z)-2-methylbut-2-enoate
4,5,7a,7b-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethyl]-hexahydro-1ah-naphtho[1,2-b]oxiren-6-yl 2-methylbut-2-enoate
10β,13,14-trihydroxyalloaromadendrane
{"Ingredient_id": "HBIN000059","Ingredient_name": "10\u03b2,13,14-trihydroxyalloaromadendrane","Alias": "NA","Ingredient_formula": "C21H36O8","Ingredient_Smile": "CC1CCC2C1C3C(C3(C)CO)CCC2(COC4C(C(C(C(O4)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "42560","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1s,4s,5r,7r,10r)-11,14-dihydroxyguai-3-one11-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN003289","Ingredient_name": "(1s,4s,5r,7r,10r)-11,14-dihydroxyguai-3-one11-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H36O8","Ingredient_Smile": "CC1C2CC(CCC(C2CC1=O)CO)C(C)(C)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15108","TCMID_id": "5901","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5-epi-vibsanin c
{"Ingredient_id": "HBIN011533","Ingredient_name": "5-epi-vibsanin c","Alias": "NA","Ingredient_formula": "C25H36O5","Ingredient_Smile": "CC(=CCCC1(CC=C(C(=O)C(C1C=COC(=O)C=C(C)C)CC(=O)C)CO)C)C","Ingredient_weight": "416.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7032","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10319743","DrugBank_id": "NA"}
5-epi-vibsanin e
{"Ingredient_id": "HBIN011534","Ingredient_name": "5-epi-vibsanin e","Alias": "NA","Ingredient_formula": "C25H36O5","Ingredient_Smile": "CC(=CC(=O)OC=CC1C(C(=O)C2COC(C3C2CC1(CC3)C)(C)C)CC(=O)C)C","Ingredient_weight": "416.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "7033","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "44185775","DrugBank_id": "NA"}
alatoside a
{"Ingredient_id": "HBIN015044","Ingredient_name": "alatoside a","Alias": "NA","Ingredient_formula": "C21H36O8","Ingredient_Smile": "CC(=C)C1CCC2(C(C1)C(CC(C2OC3C(C(C(C(O3)CO)O)O)O)O)(C)O)C","Ingredient_weight": "416.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "838","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11144190","DrugBank_id": "NA"}
atractyloside g
{"Ingredient_id": "HBIN017307","Ingredient_name": "atractyloside g","Alias": "NA","Ingredient_formula": "C21H36O8","Ingredient_Smile": "CC12CCC(CC1C(=C)C(C(C2)O)O)C(C)(C)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "416.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14423","TCMID_id": "1979","TCMSP_id": "NA","TCM_ID_id": "6487","PubChem_id": "101831405","DrugBank_id": "NA"}